GE HealthCareGEHCEarnings & Financial Report
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Dia...
GEHC Q4 2025 Key Financial Metrics
売上高
$5.7B
粗利益
$2.3B
営業利益
$827.0M
純利益
$588.0M
粗利益率
39.7%
営業利益率
14.5%
純利益率
10.3%
前年比成長
7.1%
EPS
$1.28
資金フロー
GE HealthCare Q4 2025 Financial Summary
GE HealthCare reported revenue of $5.7B for Q4 2025, with a net profit of $588.0M (10.3% margin). Cost of goods sold was $3.4B, operating expenses totaled $1.4B.
Key Financial Metrics
| Total Revenue | $5.7B |
|---|---|
| Net Profit | $588.0M |
| Gross Margin | 39.7% |
| Operating Margin | 14.5% |
| Report Period | Q4 2025 |
GE HealthCare Annual Revenue by Year
GE HealthCare annual revenue history includes year-by-year totals (for example, 2025 revenue was $20.6B).
| Year | Annual Revenue |
|---|---|
| 2025 | $20.6B |
| 2024 | $19.7B |
| 2023 | $19.6B |
| 2022 | $18.3B |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $4.65B | $4.84B | $4.86B | $5.32B | $4.78B | $5.01B | $5.14B | $5.70B |
| 前年比成長 | -1.2% | 0.5% | 0.9% | 2.2% | 2.7% | 3.5% | 5.8% | 7.1% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $32.21B | $31.85B | $33.85B | $33.09B | $33.59B | $35.50B | $36.13B | $36.91B |
| 総負債 | $24.61B | $23.86B | $25.34B | $24.44B | $24.17B | $25.55B | $25.91B | $26.31B |
| 株主資本 | $7.41B | $7.80B | $8.32B | $8.45B | $9.19B | $9.71B | $9.99B | $10.38B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|
| 営業CF | $419.0M | $-119.0M | $250.0M | $94.0M |
Other Health Care Companies
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B
BDX
Becton Dickinson
売上高
$5.3B
純利益
$382.0M
BSX
Boston Scientific
売上高
$5.3B
純利益
$670.0M
DXCM
Dexcom
売上高
$1.3B
純利益
$267.3M
EW
Edwards Lifesciences
売上高
$1.6B
純利益
$291.1M
HOLX
Hologic
売上高
$1.0B
純利益
$179.1M
IDXX
Idexx Laboratories
売上高
$1.1B
純利益
$274.6M
PODD
Insulet Corporation
売上高
$783.7M
純利益
$101.6M
ISRG
Intuitive Surgical
売上高
$2.9B
純利益
$794.8M